These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15198676)

  • 1. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.
    Gao L; Wang J; Wang Y; Andreadis A
    Mol Cell Neurosci; 2007 Jan; 34(1):48-58. PubMed ID: 17137791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.
    Wu JY; Kar A; Kuo D; Yu B; Havlioglu N
    Mol Cell Biol; 2006 Sep; 26(18):6739-47. PubMed ID: 16943417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
    Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
    Wang Y; Wang J; Gao L; Lafyatis R; Stamm S; Andreadis A
    J Biol Chem; 2005 Apr; 280(14):14230-9. PubMed ID: 15695522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.
    Hartmann AM; Rujescu D; Giannakouros T; Nikolakaki E; Goedert M; Mandelkow EM; Gao QS; Andreadis A; Stamm S
    Mol Cell Neurosci; 2001 Jul; 18(1):80-90. PubMed ID: 11461155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
    Wang Y; Gao L; Tse SW; Andreadis A
    Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
    Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
    J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alternative splicing of tau exon 10.
    Qian W; Liu F
    Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kalbfuss B; Mabon SA; Misteli T
    J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
    Kar A; Havlioglu N; Tarn WY; Wu JY
    J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.
    Stoilov P; Daoud R; Nayler O; Stamm S
    Hum Mol Genet; 2004 Mar; 13(5):509-24. PubMed ID: 14709600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.